Chirale organische Verbindungen

Ac-D-Trp-OH

L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester

Ruthenate(1-), bis[1,1'-(1R)-[1,1'-binaphthalene]-2,2'-diylbis[1,1-diphenylphosphine-κP]]tri-μ-chlorodichlorodi-, stereoisomer, hydrogen, compd. with N-methylmethanamine (1:1:1)

1,3-Dioxane-4-acetic acid, 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6S)-

(R)-1-acetyl-2-PyrrolidineMethanol

1-METHYL-4-(METHYLSULFINYL)BENZENE

Benzenesulfonamide, N-[(1S,2S)-2-amino-1,2-diphenylethyl]-4-methyl-

(2S,3S)-2,3-Bis(pivaloyloxy)succinic acid

Ac-2-Nal-OH

Carbamic acid, N-[(1S)-1-(hydroxymethyl)-2-phenylethyl]-, 9H-fluoren-9-ylmethyl ester

3-Butyn-2-amine, hydrochloride (1:1), (2S)-

(S)-(+)-DBD-APY

(R)-N-(4-nitrophenethyl)-2-hydroxy-2-phenylacetamide

3-Oxazolidinecarboxylic acid, 4-(1-methylethyl)-2,5-dioxo-, phenylmethyl ester, (4S)-

FMOC-α-METHYL-L-PHE

(S,R,R)-(+)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a:3,4-a′]dinaphthalen-4-yl)bis(1-phenylethyl)amine

1-Piperazinecarboxylic acid, 2-cyclopropyl-, 1,1-dimethylethyl ester, (2S)-

Z-LYS(BOC)-ONP

D-epi-Inositol, 3,4-dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-[(phenylmethoxy)methyl]-1,5,6-tris-O-(phenylmethyl)-

1,2-Cyclohexanedicarboxylic acid, 4-oxo-, 1,2-dimethyl ester, (1R,2R)-rel-

1,2-Cyclopropanedicarboxylic acid, monoethyl ester, (1R,2R)-

(3R,4R)-rel-4-Fluoropiperidin-3-ol hydrochloride

(S)-2-PHENYLPIPERIDINE

1H-Indene-2-acetic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,3-dihydro-, (αR)-

Pyrrolidine, 3-ethoxy-, (3S)-

(R)-(+)-2,2'-BIS(DIPHENYLPHOSPHINO)-1,1'-BINAPHTHALENECHLORO(P-CYMENE)RUTHENIUM CHLORIDE

Benzenepropanoic acid, β-amino-3-chloro-, (βR)-

FMOC-SER(AC)-OH

1H-1,4-Diazepine-1-carboxylic acid, hexahydro-7-methyl-, 1,1-dimethylethyl ester, (7R)-

4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2S)-

L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-fluoro-

2,7-(Epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione,25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-,(2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-

D-Valinol

1-((6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f ][1,3,5,2,4]trioxadisilocin-8-yl)pyriMidine-2,4(1H,3H)-dione

H-Hyp-OEt.HCl

L-Serine, O-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-

(R)-1-BOC-3-HYDROXYMETHYLPIPERIDINE ETHYL ESTER

Ethyl (R)-(-)-2-Hydroxy-4-Phenylbutyrate

(5S)-5-(trifluoroMethyl)-2-Pyrrolidinone

Pyridine, 2-[(3R)-3-pyrrolidinyloxy]-, hydrochloride (1:2)

(R)RuCl[(pcymene)(DMBINAP)]Cl

(6R)-6-methylmorpholin-3-one

(1S,2S)-1,2-CyclohexanediMethanol

b-D-Mannopyranose, 1,6:2,3-dianhydro-

2H-Pyrido[3,4-b]indole-2,3-dicarboxylic acid, 1,3,4,9-tetrahydro-, 2-(1,1-dimethylethyl) ester, (3R)-

Atorvastatin Lactam Sodium Salt Impurity

Benzenemethanamine, 3-fluoro-α-(trifluoromethyl)-, hydrochloride (1:1), (αS)-

FMOC-ILE-OL

(R)-(+)-2-Methyl-2-Propanesulfinamide

(Z-Cys-OH)2

Phosphine, (1R)-[1,1'-binaphthalene]-2,2'-diylbis[bis(4-methylphenyl)-

6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hepta-1,5-diene

ND-630

3H-Furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione,11-(acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-, (1S,6bR,9aS,11R,11bR)-

H-Hyp-OMe.HCl

N-[4-[(4S)-2,5-dioxooxazolidin-4-yl]butyl]-2,2,2-trifluoro-acetamide

(S)-1-N-Cbz-Pipecolinic acid

5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid, 5-(1,1-dimethylethyl) ester, potassium salt (1:1), (6S)-

(3R,4S)-4-aminooxan-3-ol hydrochloride

Benzenemethanol, α-methyl-3,5-bis(trifluoromethyl)-, (αR)-

Benzenemethanamine, 3,4-difluoro-α-methyl-, (alphaR)- (9CI)

4-Pentenoic acid, 2-amino-, (2S)-

Tamsulosin hydrochloride

D-Galacturonic acid, sodium salt (1:1)

(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanoic Acid

Phosphine, 1,1'-(4S)-[4,4'-bi-1,3-benzodioxole]-5,5'-diylbis[1,1-bis[3,5-bis(1,1-dimethylethyl)-4-methoxyphenyl]-

cis-Octahydro-1H-isoindole hydrochloride

(S)-Morpholine-3-carboxylic acid

D-Phenylalanine, N-acetyl-

4-Fluoro-L-Phenylalanine Ethyl Ester Hydrochloride (1:1)

FMOC-(R)-3-AMINO-3-(3-NITRO-PHENYL)-PROPIONIC ACID

9,10-Ethanoanthracene-11,12-diamine, 9,10-dihydro-, (11S,12S)-

Daptomycin

1-Pyrrolidinecarboxylic acid, 3-(aminomethyl)-, phenylmethyl ester, hydrochloride (1:1), (3R)-

(R)-Methyl 2-(tert-butoxycarbonylamino)-3-iodopropanoate

Z-β-Dab(Boc)-OH

L-Cystine, N,N'-dibenzoyl-

Boc-(S)-3-thienylglycine

5-Pyrimidinecarboxylic acid, 4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-, ethyl ester

(2S,4R)-1-(tert-Butoxycarbonyl)-4-phenylpyrrolidine-2-carboxylic acid

6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one,2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-7-methyl-,(2R,3R,3aS,9aR)-

(R)-3,3-Difluoro-cyclopentanemethanol

(S)-1-Boc-3-hydroxypiperidine

Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 4-hydroxy-, 4-oxide,(11bS)-

(S)-3-(HYDOXYMETHYL)-1-METHYLPYRROLIDINE

(2R,3R)-Butane-2,3-diylbis(diphenylphosphine)

1-Piperidinecarboxylic acid, 3-amino-4-hydroxy-, phenylmethyl ester, (3R,4R)-

3H-Pyrrolo[1,2-c][1,2,3]oxathiazole, tetrahydro-, 1,1-dioxide, (3aS)-

(R)-3-(2-Methoxyethoxy)pyrrolidine

DICHLORO[(R)-(+)-2,2'-BIS(DIPHENYLPHOSPHINO)-1,1'-BINAPHTHYL]RUTHENIUM (II)

Bafetinib

(R)-3-Cyanopiperidine hydrochloride

L-Proline, N-(methoxycarbonyl)-L-valyl-

(3R)-N-Methyl-3-piperidinecarboxamide HCl

Oxirane, 2-phenyl-, (2R)-

Benzenepropanoic acid, b-amino-a-hydroxy-, ethyl ester, [R-(R*,S*)]-

((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(methylene) bis(4-methylbenzenesulfonate)

1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol

1,2-Pyrrolidinedicarboxylic acid, 4-oxo-, 1-(1,1-dimethylethyl) 2-methyl ester, (2S)-

(2R,4R)-2-methylpiperidin-4-ol hydrochloride